These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 25557916)

  • 1. Crk and CrkL are required for cell transformation by v-fos and v-ras.
    Koptyra M; Park TJ; Curran T
    Mol Carcinog; 2016 Jan; 55(1):97-104. PubMed ID: 25557916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Essential roles of Crk and CrkL in fibroblast structure and motility.
    Park TJ; Curran T
    Oncogene; 2014 Oct; 33(43):5121-32. PubMed ID: 24166500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibroblast Growth Requires CT10 Regulator of Kinase (Crk) and Crk-like (CrkL).
    Park T; Koptyra M; Curran T
    J Biol Chem; 2016 Dec; 291(51):26273-26290. PubMed ID: 27807028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adaptor proteins CRK and CRKL associate with the serine/threonine protein kinase GCKR promoting GCKR and SAPK activation.
    Shi CS; Tuscano J; Kehrl JH
    Blood; 2000 Feb; 95(3):776-82. PubMed ID: 10648385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physiological signals and oncogenesis mediated through Crk family adapter proteins.
    Feller SM; Posern G; Voss J; Kardinal C; Sakkab D; Zheng J; Knudsen BS
    J Cell Physiol; 1998 Dec; 177(4):535-52. PubMed ID: 10092207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crk and CrkL present with different expression and significance in epithelial ovarian carcinoma.
    Wang J; Che YL; Li G; Liu B; Shen TM; Wang H; Linghu H
    Mol Carcinog; 2011 Jul; 50(7):506-15. PubMed ID: 21319228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paradoxical tumor inhibitory effect of p53 loss in transgenic mice expressing epidermal-targeted v-rasHa, v-fos, or human transforming growth factor alpha.
    Greenhalgh DA; Wang XJ; Donehower LA; Roop DR
    Cancer Res; 1996 Oct; 56(19):4413-23. PubMed ID: 8813135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell shape-based chemical screening reveals an epigenetic network mediated by focal adhesions.
    Kanazawa T; Michida H; Uchino Y; Ishihara A; Zhang S; Tabata S; Suzuki Y; Imamoto A; Okada M
    FEBS J; 2021 Oct; 288(19):5613-5628. PubMed ID: 33768715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Requirement for Crk and CrkL during postnatal lens development.
    Park T; Curran T
    Biochem Biophys Res Commun; 2020 Aug; 529(3):603-607. PubMed ID: 32736680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CRKL plays a pivotal role in tumorigenesis of head and neck squamous cell carcinoma through the regulation of cell adhesion.
    Yanagi H; Wang L; Nishihara H; Kimura T; Tanino M; Yanagi T; Fukuda S; Tanaka S
    Biochem Biophys Res Commun; 2012 Feb; 418(1):104-9. PubMed ID: 22244889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A role for Ras in v-Crk transformation.
    Greulich H; Hanafusa H
    Cell Growth Differ; 1996 Nov; 7(11):1443-51. PubMed ID: 8930393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Essential role of the
    Imamoto A; Ki S; Li L; Iwamoto K; Maruthamuthu V; Devany J; Lu O; Kanazawa T; Zhang S; Yamada T; Hirayama A; Fukuda S; Suzuki Y; Okada M
    Life Sci Alliance; 2020 Feb; 3(2):. PubMed ID: 32041892
    [No Abstract]   [Full Text] [Related]  

  • 13. Quantitative assessment of glioblastoma phenotypes in vitro establishes cell migration as a robust readout of Crk and CrkL activity.
    Park T; Large N; Curran T
    J Biol Chem; 2021; 296():100390. PubMed ID: 33561443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crk at the quarter century mark: perspectives in signaling and cancer.
    Kumar S; Fajardo JE; Birge RB; Sriram G
    J Cell Biochem; 2014 May; 115(5):819-25. PubMed ID: 24356912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of highly selective SH3 binding peptides for Crk and CRKL which disrupt Crk-complexes with DOCK180, SoS and C3G.
    Posern G; Zheng J; Knudsen BS; Kardinal C; Müller KB; Voss J; Shishido T; Cowburn D; Cheng G; Wang B; Kruh GD; Burrell SK; Jacobson CA; Lenz DM; Zamborelli TJ; Adermann K; Hanafusa H; Feller SM
    Oncogene; 1998 Apr; 16(15):1903-12. PubMed ID: 9591773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Avian and 1918 Spanish influenza a virus NS1 proteins bind to Crk/CrkL Src homology 3 domains to activate host cell signaling.
    Heikkinen LS; Kazlauskas A; Melén K; Wagner R; Ziegler T; Julkunen I; Saksela K
    J Biol Chem; 2008 Feb; 283(9):5719-27. PubMed ID: 18165234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CRKL regulates alternative splicing of cancer-related genes in cervical cancer samples and HeLa cell.
    Song Q; Yi F; Zhang Y; Jun Li DK; Wei Y; Yu H; Zhang Y
    BMC Cancer; 2019 May; 19(1):499. PubMed ID: 31133010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. B-ATF functions as a negative regulator of AP-1 mediated transcription and blocks cellular transformation by Ras and Fos.
    Echlin DR; Tae HJ; Mitin N; Taparowsky EJ
    Oncogene; 2000 Mar; 19(14):1752-63. PubMed ID: 10777209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crk adaptor proteins act as key signaling integrators for breast tumorigenesis.
    Fathers KE; Bell ES; Rajadurai CV; Cory S; Zhao H; Mourskaia A; Zuo D; Madore J; Monast A; Mes-Masson AM; Grosset AA; Gaboury L; Hallet M; Siegel P; Park M
    Breast Cancer Res; 2012 May; 14(3):R74. PubMed ID: 22569336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of CT10 regulation of kinase-like in cancer.
    Guo C; Liu S; Sun MZ
    Future Oncol; 2014 Dec; 10(16):2687-97. PubMed ID: 25531052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.